SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hikal - Quaterly Results

08 Aug 2023 Evaluate
The Total revenue for the quarter ended June 2023 of  Rs. 3880.50 millions remain, more or less, the same.The Total Profit for the quarter ended June 2023 of Rs. 68.60 millions grew from Rs.-89.40 millionsOperating profit surged to 511.70 millions from the corresponding previous quarter of 259.40 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 3880.50 3787.90 2.44 3880.50 3787.90 2.44 20230.30 19427.20 4.13
Other Income 9.40 32.70 -71.25 9.40 32.70 -71.25 54.10 48.90 10.63
PBIDT 511.70 259.40 97.26 511.70 259.40 97.26 2624.70 3454.50 -24.02
Interest 137.90 112.90 22.14 137.90 112.90 22.14 481.00 312.10 54.12
PBDT 373.80 146.50 155.15 373.80 146.50 155.15 2143.70 3142.40 -31.78
Depreciation 277.30 265.00 4.64 277.30 265.00 4.64 1090.10 956.70 13.94
PBT 96.50 -118.50 -181.43 96.50 -118.50 -181.43 1053.60 2185.70 -51.80
TAX 27.90 -29.10 -195.88 27.90 -29.10 -195.88 269.80 580.60 -53.53
Deferred Tax 0.70 -29.10 -102.41 0.70 -29.10 -102.41 -35.00 -15.90 120.13
PAT 68.60 -89.40 -176.73 68.60 -89.40 -176.73 783.80 1605.10 -51.17
Equity 246.60 246.60 0.00 246.60 246.60 0.00 246.60 246.60 0.00
PBIDTM(%) 13.19 6.85 92.56 13.19 6.85 92.56 12.97 17.78 -27.04

Hikal Share Price

192.15 3.60 (1.91%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×